WASHINGTON - As retailers prepare for final sales restrictions on cough and cold medicines containing pseudoephedrine that go into effect at the end of this week, the compound that replaced it on store shelves has come under fire as "ineffective." In a letter to the editor published in the July issue of the Journal of Allergy and Clinical Immunology, Leslie Hendeles and Randy C. Hatton, pharmacists at the University of Florida, cited research that they said shows phenylephrine isn't ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
 

Click here to read the FAQ page if you have any questions (opens in a new window)
 

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.